| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9B | $11.9B | $12.1B | $13.8B | $11.7B | $2.4B | $2.5B | $2.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.2B | $2.7B | $2.6B | $2.1B | $1.8B | $0.2B | $0.2B | $-0.2B |
| Net Income | $1.8B | $1.1B | $2.4B | $1.1B | $1.1B | $1.4B | $1.2B | $0.8B |
| EPS (Basic) | $3.98 | $2.47 | $11.14 | $5.40 | $5.57 | $1.95 | $1.96 | $-0.37 |
| EPS (Diluted) | $3.91 | $2.45 | $11.10 | $5.37 | $5.54 | $1.93 | $1.94 | $-0.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $71.9B | $64.8B | $59.7B | $58.6B | $59.5B | $58.2B | $51.7B | $48.3B |
| Current Assets | $5.8B | $4.4B | $3.7B | $4.1B | $3.6B | $4.6B | $3.0B | $3.0B |
| Cash & Equivalents | $1.9B | $0.9B | $0.1B | $0.2B | $0.4B | $1.8B | $0.4B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $7.8B | $6.1B | $6.4B | $6.4B | $6.2B | $7.1B | $5.6B | $5.4B |
| Stockholders' Equity | $16.9B | $15.1B | $14.6B | $13.0B | $11.6B | $10.9B | $10.2B | $8.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.2B | $4.5B | $4.3B | $2.6B | $2.3B | $2.7B | $2.8B | $2.4B |
| Investing Cash Flow | $-7.1B | $-5.8B | $-4.6B | $-5.7B | $-6.2B | $-4.8B | $-4.5B | $-4.1B |
| Capital Expenditures | $7.7B | $4.8B | — | — | — | — | — | — |
| Financing Cash Flow | $3.0B | $2.1B | $0.2B | $2.9B | $2.6B | $3.4B | $1.6B | $1.4B |